Craig R. Rayner - Sep 2, 2021 Form 4 Insider Report for Certara, Inc. (CERT)

Role
PRESIDENT, INTEGRATED DRUG DEV
Signature
/s/ Richard M. Traynor, Attorney-in Fact for Craig R. Raynor
Stock symbol
CERT
Transactions as of
Sep 2, 2021
Transactions value $
-$1,978,664
Form type
4
Date filed
9/7/2021, 05:16 PM
Previous filing
Jun 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERT Common Stock Sale -$131K -3.9K -1.05% $33.51 367K Sep 2, 2021 Direct F1, F2
transaction CERT Common Stock Sale -$64.9K -1.9K -0.52% $34.15 365K Sep 2, 2021 Direct F3, F4
transaction CERT Common Stock Sale -$1.78M -48.5K -13.29% $36.64 316K Sep 2, 2021 Direct F5, F6
transaction CERT Common Stock Sale -$7.44K -200 -0.06% $37.21 316K Sep 2, 2021 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $32.91 to $33.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F4 This transaction was executed in multiple trades at prices ranging from $34.12 to $34.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F6 This transaction was executed in multiple trades at prices ranging from $36.19 to $37.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F8 This transaction was executed in multiple trades at prices ranging from $37.21 to $37.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.